Pancreatic Cancer Research

ResearcherZhejiang Provincial People's HospitalNo recent work listed

Ying‐Yu Ma

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113378255. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper

Papers 3

  1. Role of Treg/Th17 Imbalance, Microbiota and miRNAs in Pancreatic Cancer: Therapeutic Options. Last author DOI 10.1615/critrevimmunol.2020033631↗
  2. Synergistic antitumor effects of CDK inhibitor SNS‑032 and an oncolytic adenovirus co‑expressing TRAIL and Smac in pancreatic cancer. Co-author DOI 10.3892/mmr.2017.6472↗
  3. AUTS2 is a potential therapeutic target for pancreatic cancer patients with liver metastases. Co-author DOI 10.1016/j.mehy.2015.04.029↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maohua Cai · 1 shared paper, 2020 · strength 0.13
  2. Xue Yang · 1 shared paper, 2020 · strength 0.13
  3. Luo‐Qin Fu · 1 shared paper, 2020 · strength 0.13
  4. Weiwei Jin · 1 shared paper, 2020 · strength 0.13
  5. Yiping Mou · 1 shared paper, 2020 · strength 0.13
  6. Shibing Wang · 1 shared paper, 2017 · strength 0.07
  7. Yigang Wang · 1 shared paper, 2017 · strength 0.07
  8. Yun Ge · 1 shared paper, 2017 · strength 0.07
  9. Hui‐Ju Wang · 1 shared paper, 2015 · strength 0.05
  10. Dong‐Sheng Huang · 1 shared paper, 2015 · strength 0.05
  11. Yong Kwon Han · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.